Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.21 USD | +10.92% | +9.09% | -12.45% |
Mar. 21 | North American Morning Briefing : Investors -2- | DJ |
Jan. 11 | Acorda Therapeutics, Inc. to Regain Global Commercialization Rights to FAMPYRA by January 2025 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-12.45% | 16.41M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-36.53% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Acorda Therapeutics, Inc. - Nasdaq
- News Acorda Therapeutics, Inc.
- Acorda Therapeutics : Completes 1-for-6 Reverse Stock Split